Clinical Trial Update: A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A [Phase 1]

View source ↗

Summary

First-in-human Phase 1 study to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of HM12460A completed, assessing initial safety in healthy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• HM12460A

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Healthy, Type 1 Diabetes Mellitus | Phase 1 | Status: COMPLETED